Boston Scientific Corporation Market Cap: 8.79B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BSX Market Cap Rankings
| Overall | 88th percentile | 529 of 4673 |
| Sector | 91st percentile | 44 of 530 in Healthcare |
| Industry | 91st percentile | 7 of 79 in Medical Appliances & Equipment |
BSX Market Cap Range, Past 5 Years
| Minimum | 5.47B | Dec 2000 |
| Maximum | 35.74B | Jun 2004 |
| Average | 19.99B |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these BSX related companies
BSX News
Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
Feb 08, 8:30AM PR Newswire
Feb 08, 8:30AM PR Newswire
Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference
Feb 07, 2:00PM PR Newswire
Feb 07, 2:00PM PR Newswire
Boston Scientific (BSX)Get Trifecta of Positive Data from WallFlex Stent Studies
Feb 07, 8:31AM Street Insider
Feb 07, 8:31AM Street Insider
Boston Scientific WallFlex® Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries
Feb 07, 8:30AM PR Newswire
Feb 07, 8:30AM PR Newswire
Boston Scientific Announces Global Launch of Expect™ 19 Flex Endoscopic Ultrasound Aspiration Needle
Feb 06, 8:30AM PR Newswire
Feb 06, 8:30AM PR Newswire
Jefferies Maintains a 'Hold' on Boston Scientific (BSX); Remaining Cloudy Until 2013...Or Later
Feb 03, 2:21PM Street Insider
Feb 03, 2:21PM Street Insider
@gtotoy bought some $bsx 6 calls @.15 . some momo happening so it's a flyer
about 9 days ago by teddowns
about 9 days ago by teddowns
Research Reports for Penny Stock Top Movers: Ford, Boston Scientific, and AK Steel Holding
Feb 03, 8:50AM PR Newswire
Feb 03, 8:50AM PR Newswire
Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 02, 3:50PM Seeking Alpha
Feb 02, 3:50PM Seeking Alpha
Listen to $BSX Q4 2011 earnings call - live at 08:00 AM, ondemand after - http://stks.co/2Cto
about 10 days ago by earningscast
about 10 days ago by earningscast
Boston Scientific Corp. (BSX) Tops Q4 EPS by 5c, Offers Q1 Sales Guidance
Feb 02, 7:01AM Street Insider
Feb 02, 7:01AM Street Insider
$BSX now finding support at the 8 day ema and looks like it might be headed up to test last week's highs. Strong in a weak tape
about 13 days ago by Catalystrader
about 13 days ago by Catalystrader
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BSX | 5.93 | -0.02 | -0.34% | 8.79B |
| DAL | 10.89 | -0.23 | -2.07% | 9.21B |
| WFC | 30.26 | -0.32 | -1.05% | 159.58B |
| PAR | 5.09 | -0.01 | -0.20% | 77.16M |
| PTR | 146.63 | -5.09 | -3.35% | 268.33B |
| ANX | 0.71 | -0.01 | -0.78% | 18.93M |
| WYN | 44.15 | -0.12 | -0.27% | 6.80B |
| BCE | 39.25 | -0.53 | -1.33% | 30.52B |
| DIT | 65.30 | 0.03 | 0.04% | 40.48M |
| JRCC | 6.38 | -0.51 | -7.40% | 227.13M |
